DJIA 18,082.91 70.97 0.39%
NASDAQ 5,095.40 18.87 0.37%
S&P 500 2,113.20 3.60 0.17%
market minute promo

Biogen Idec (NASDAQ: BIIB)

company name or ticker
Company Photos
(Click to zoom)

Is This Why the Street Keeps Doubting Gilead Sciences, Inc.?

Gilead Sciences looks like a screaming buy right now based on its fundamentals. But the Street apparently doesn't think so. Here's why.

Kythera's (KYTH) Double Chin Drug Kybella Gets FDA Nod - Analyst Blog

Will Isis Pharmaceuticals (ISIS) Disappoint in Q1 Earnings? - Analyst Blog

3 Stocks Improving Performance Of The Health Care Sector

Biotech's Blue Chip Stocks

Traditionally, the consumer goods or technology sector is where you'd find most "blue chip stocks," but over the past decade a number of blue chip stocks have emerged within biotech. Here are the four you should be paying close attention to.

Biogen Making A Breakthrough In Treating Alzheimer's

Oncolytics' Reolysin Gets Another Orphan Drug Status in EU - Analyst Blog

Bristol-Myers' Supplemental BLA for Opdivo Accepted by FDA - Analyst Blog

Vanguard Healthcare Fund Adds Four New Positions

Seeking Alpha's Biotech Weekly: A Gilead Victory, Celladon Crumbles, And More

See More Articles...